These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2220657)

  • 21. [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer].
    Taguchi T; Ohta J; Orino M; Ohshiba S; Yamada S; Okazima K; Ohtani T; Hurukawa H; Iwanaga T; Numata N
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2191-6. PubMed ID: 2241183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of gastric carcinoma remarkably responding to etoposide, adriamycin and cisplatin (EAP) therapy].
    Nakamura Y; Hamada H; Yoshinobu H; Mori N; Nakajima I; Kurooka K; Tanaka A; Nakamura T; Yasutomi M
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2995-8. PubMed ID: 3178244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
    Kelsen D; Atiq OT; Saltz L; Niedzwiecki D; Ginn D; Chapman D; Heelan R; Lightdale C; Vinciguerra V; Brennan M
    J Clin Oncol; 1992 Apr; 10(4):541-8. PubMed ID: 1548519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
    Matsumura T; Ohnoshi T; Ueoka H; Kiura K; Tabata M; Genba K; Chikamori M; Ikubo S; Matsuo K; Kimura I
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):261-4. PubMed ID: 8311499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease.
    Preusser P; Wilke H; Achterrath W; Fink U; Neuhaus P; Meyer J; Meyer HJ; van de Loo J
    Recent Results Cancer Res; 1988; 110():198-206. PubMed ID: 3406503
    [No Abstract]   [Full Text] [Related]  

  • 27. FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
    Bajetta E; Di Bartolomeo M; Carnaghi C; Buzzoni R; Mariani L; Gebbia V; Comella G; Pinotti G; Ianniello G; Schieppati G; Bochicchio AM; Maiorino L
    Br J Cancer; 1998 Apr; 77(7):1149-54. PubMed ID: 9569054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of etoposide (V), adriamycin (A), and cisplatinum (P) in patients with metastatic gastric cancer.
    Katz A; Gansl RC; Simon SD; Gama-Rodrigues J; Waitzberg D; Bresciani CJ; Pinotti HW
    Am J Clin Oncol; 1991 Aug; 14(4):357-8. PubMed ID: 1862768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
    Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
    Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: association with severe myelotoxicity.
    Bar-Sela G; Tsalic M; Gaitini D; Steiner M; Haim N
    Med Oncol; 2003; 20(3):291-4. PubMed ID: 14514979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
    Wang X; Pang L; Feng J
    Am J Clin Oncol; 2002 Feb; 25(1):71-5. PubMed ID: 11823701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
    Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
    Miller AA; Herndon JE; Hollis DR; Ellerton J; Langleben A; Richards F; Green MR
    J Clin Oncol; 1995 Aug; 13(8):1871-9. PubMed ID: 7636529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced inoperable stomach cancer: a pilot study with the combination etoposide, adriamycin and cisplatin.
    Preusser P; Wilke H; Achterrath W; Neuhaus B; Balleisen L; Meyer J; Van de Loo J
    Anticancer Res; 1986; 6(5):1195-6. PubMed ID: 3800325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
    Ohwada S; Miyamoto Y; Takeshita M; Fujii T; Uchida O; Tanahasi Y; Aoyagi H; Izuo M
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3487-9. PubMed ID: 2802641
    [No Abstract]   [Full Text] [Related]  

  • 37. Etoposide, doxorubicin and cisplatin alternating with 5-fluorouracil, doxorubicin and high-dose methotrexate in patients with advanced adenocarcinoma of the stomach or the gastroesophageal junction.
    Bar Sela G; Tsalic M; Gaitini D; Steiner M; Haim N
    J Chemother; 2002 Dec; 14(6):623-6. PubMed ID: 12583555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer.
    Tabata M; Kiura K; Okimoto N; Segawa Y; Shinkai T; Yonei T; Kuyama S; Harita S; Hotta K; Ueoka H; Tanimoto M
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):1-6. PubMed ID: 17393168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of capecitabine plus cisplatin in patients with gastric cancer.
    Salah-Eldin MA; Ebrahim MA; AL-Ashry MS
    Anticancer Drugs; 2009 Mar; 20(3):191-6. PubMed ID: 19396018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Etoposide, doxorubicin, cisplatin and 5-FU (EAP-F) therapy of advanced gastric cancer--its antitumor effect and evaluation of quality of life].
    Suda K; Kano Y; Inada T; Ogata Y
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1791-5. PubMed ID: 8379671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.